脑脊液诊断管理干预对检查数量、住院时间、抗生素处方及费用的影响。
Impact of a cerebrospinal fluid diagnostic stewardship intervention on quantity of tests, length of stay, antibiotic prescriptions, and cost.
作者信息
Pathak Aaron, Shay Sabra, Lasco Todd, Al Mohajer Mayar
机构信息
School of Medicine, Baylor College of Medicine, Houston, TX, USA.
Department of Clinical Intelligence, Premier Inc., Charlotte, NC, USA.
出版信息
Antimicrob Steward Healthc Epidemiol. 2025 Feb 11;5(1):e35. doi: 10.1017/ash.2025.17. eCollection 2025.
Abstract
Redundant and low-value cerebrospinal fluid analysis for suspected meningitis can increase costs and antimicrobial use. Our diagnostic stewardship intervention limited available infectious disease cerebrospinal fluid assays to seven common tests, including a multiplex polymerase chain reaction panel. There was no significant difference in the cost of testing or clinical outcomes.
摘要
对疑似脑膜炎进行多余且低价值的脑脊液分析会增加成本和抗菌药物的使用。我们的诊断管理干预措施将可用的感染性疾病脑脊液检测项目限制为七项常见检测，包括一个多重聚合酶链反应检测板。检测成本或临床结果没有显著差异。
相似文献
1
Impact of a cerebrospinal fluid diagnostic stewardship intervention on quantity of tests, length of stay, antibiotic prescriptions, and cost.
Antimicrob Steward Healthc Epidemiol. 2025 Feb 11;5(1):e35. doi: 10.1017/ash.2025.17. eCollection 2025.
2
Diagnostic Accuracy of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction Panel Testing in Patients With Suspected Central Nervous System Infections: A Multi-Center Study in the United Arab Emirates.
Cureus. 2024 Jan 8;16(1):e51906. doi: 10.7759/cureus.51906. eCollection 2024 Jan.
3
Clinical and Financial Impact of a Diagnostic Stewardship Program for Children with Suspected Central Nervous System Infection.
J Pediatr. 2022 May;244:161-168.e1. doi: 10.1016/j.jpeds.2022.02.002. Epub 2022 Feb 9.
4
Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger.
Pediatrics. 2007 Sep;120(3):489-96. doi: 10.1542/peds.2007-0252.
5
How do we reduce acyclovir overuse? Impact of FilmArray meningitis/encephalitis panel tests for pediatric patients.
J Infect Chemother. 2022 Sep;28(9):1261-1265. doi: 10.1016/j.jiac.2022.05.005. Epub 2022 May 14.
6
Syndromic Multiplex Polymerase Chain Reaction (mPCR) Testing and Antimicrobial Stewardship: Current Practice and Future Directions.
Curr Infect Dis Rep. 2021;23(4):5. doi: 10.1007/s11908-021-00748-z. Epub 2021 Feb 26.
7
Evaluation of cerebrospinal fluid white blood cell count criteria for use of the BioFire® FilmArray® Meningitis/Encephalitis Panel in immunocompromised and nonimmunocompromised patients.
Diagn Microbiol Infect Dis. 2022 Mar;102(3):115605. doi: 10.1016/j.diagmicrobio.2021.115605. Epub 2021 Nov 21.
8
Clinical benefits of introducing real-time multiplex PCR for cerebrospinal fluid as routine diagnostic at a tertiary care pediatric center.
Infection. 2019 Feb;47(1):51-58. doi: 10.1007/s15010-018-1212-7. Epub 2018 Sep 5.
9
Introducing a New Polymerase Chain Reaction Panel-Based Cerebrospinal Fluid Evaluation for Encephalitis and Meningitis: Does It Influence Empiric Treatment Duration, Length of Hospital Stay, and Pathogen-Specific Diagnoses?
Open Forum Infect Dis. 2025 Apr 24;12(5):ofaf241. doi: 10.1093/ofid/ofaf241. eCollection 2025 May.
10
Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center.
Diseases. 2022 Nov 20;10(4):110. doi: 10.3390/diseases10040110.
本文引用的文献
1
The impact of the FilmArray meningitis/encephalitis panel on empiric antibiotic prescriptions in patients with suspected community-acquired meningitis.
Antimicrob Steward Healthc Epidemiol. 2024 Jul 26;4(1):e104. doi: 10.1017/ash.2024.343. eCollection 2024.
2
Progress and Challenges in Bacterial Meningitis: A Review.
JAMA. 2022 Dec 6;328(21):2147-2154. doi: 10.1001/jama.2022.20521.
3
Assessment of the Impact of a Meningitis/Encephalitis Panel on Hospital Length of Stay: A Systematic Review and Meta-Analysis.
Antibiotics (Basel). 2022 Jul 30;11(8):1028. doi: 10.3390/antibiotics11081028.
4
Multiplex Polymerase Chain Reaction Testing to Diagnose Central Nervous System Infections-A Doubled-Edged Sword.
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):124-125. doi: 10.1093/jpids/piab131.
5
Evaluation of cerebrospinal fluid white blood cell count criteria for use of the BioFire® FilmArray® Meningitis/Encephalitis Panel in immunocompromised and nonimmunocompromised patients.
Diagn Microbiol Infect Dis. 2022 Mar;102(3):115605. doi: 10.1016/j.diagmicrobio.2021.115605. Epub 2021 Nov 21.
6
Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis.
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115571. doi: 10.1016/j.diagmicrobio.2021.115571. Epub 2021 Oct 11.
7
Utilization, Yield, and Accuracy of the FilmArray Meningitis/Encephalitis Panel with Diagnostic Stewardship and Testing Algorithm.
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.00311-20.
8
Cerebrospinal Fluid Analysis With the BioFire FilmArray Meningitis/Encephalitis Molecular Panel Reduces Length of Hospital Stay in Patients With Suspected Central Nervous System Infections.
Open Forum Infect Dis. 2019 Mar 5;6(4):ofz119. doi: 10.1093/ofid/ofz119. eCollection 2019 Apr.
9
Cost Justification of the BioFire FilmArray Meningitis/Encephalitis Panel Versus Standard of Care for Diagnosing Meningitis in a Community Hospital.
J Pharm Pract. 2019 Feb;32(1):36-40. doi: 10.1177/0897190017737697. Epub 2017 Nov 1.
10
Diagnostic Stewardship-Leveraging the Laboratory to Improve Antimicrobial Use.
JAMA. 2017 Aug 15;318(7):607-608. doi: 10.1001/jama.2017.8531.
Zotero 插件